tm logo

Monitor this mark

View On USPTO

ALLYX THERAPEUTICS
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 09 Jul 2024

Last Applicant/ Owned by

Allyx Therapeutics, Inc.

470 James St., Suite 007

New Haven

CT

06513

Serial Number

97282621 filed on 24th Feb 2022

Registration Number

N/A

Correspondent Address

Glenn M. Cunningham

Glenn M. Cunningham SHIPMAN & GOODWIN LLP

HARTFORD, CT 06103-1919

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ALLYX THERAPEUTICS

Pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases, but not including products for the treatment of hemophilia

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases, but not including products for the treatment of hemophilia

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 97282621

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 102226-04

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
31st Oct 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
31st Oct 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
31st Oct 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
31st Oct 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
31st Oct 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
31st Oct 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09th Jul 2024SOU EXTENSION 2 FILED
09th Jul 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09th Jul 2024SOU TEAS EXTENSION RECEIVED
09th Jul 2024SOU EXTENSION 2 GRANTED